Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Bruker Introduce EVOQ TQ-MS to Attendees at IMSC in Kyoto Japan

Published: Wednesday, September 19, 2012
Last Updated: Wednesday, September 19, 2012
Bookmark and Share
EVOQ TQ-MS with Advance LC is designed with game-changing innovations.

Following Bruker’s successful launch of their game-changing EVOQ™ LC-triple quadrupole (LC-TQ) mass spectrometers at JASIS 2012 in Tokyo, Bruker continues with its global introduction.

The next stop in the launch tour for the EVOQ Qube and EVOQ Elite is to an international audience at the 19th International Mass Spectrometry Conference (IMSC 2012), being held in Kyoto, Japan - September 15-21.

The Bruker EVOQ is a purpose-built innovation for the applied markets. The EVOQ TQ-MS with the Advance LC is designed with game-changing innovations, such as the vacuum-insulated probe, heated electrospray, active exhaust, and IQ dual ion funnel.

Coupled with the high-performance EVOQ hardware is the equally high-performance software featuring Bruker’s unique compound-based screening (CBS) software for upfront method development on the triple quadrupole with a drag-and-drop, easy method setup.

This is in conjunction with the all new PACER™ software, which flags up chromatogram runs that fail to fall within preset customer parameters.

Rohan Thakur, Vice President of the Bruker CAM division commented on the hardware and software components of EVOQ. “CBS helps you to develop the method upstream that has already been proven to be successful in laboratories using the SCION GC-MS system. This, coupled with the PACER software, helps you flag problem chromatograms of the LOQ, solving an everyday problem in these laboratories. This provides you with a powerful software package that will help you speed up sample-to-report time for your instrument. So with the EVOQ hardware, which is only 50% of the solution - you now also have software that helps you complete the picture. We believe we have a very robust solution for an industry that requires rigorous quantitation needs”.

“If you look at the markets that we are targeting with the EVOQ Qube and EVOQ Elite products, the food-testing market environment, the environmental testing market, pain-management toxicology and discovery PK, it was important to design an instrument that delivers on this promise to reliably quantify thousands of real samples in the fastest sample-to-report time possible.

Bruker are hosting a Luncheon Seminar entitled “Game Changing Technologies in MRM Analysis” which will highlight the EVOQ hardware and software and be presented by Bruker expert Jonathan McNally, Product Manager for the new EVOQ, from the Bruker CAM division. The seminar takes place on Thursday, September 20, at 12:30 - 13:30, in the KICC 1F, Room E.

Bruker will also present numerous posters at IMSC 2012 and attendees are free to view the new EVOQ Qube and EVOQ Elite at the Bruker Exhibition, Booth E and view in 3D the fly-through from injection to detection.

Video animation and video presentations with English and Japanese narrative are available, along with the EVOQ brochure at

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bruker Announces Agreement to Acquire Michrom
Michrom Bioresources, Inc., a 20 year old, privately owned company based in Auburn, California provides liquid chromatography (LC) instrumentation, accessories, and consumables for applications in the life science, chemical and applied markets.
Monday, February 28, 2011
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Acetaldehyde and Formaldehyde Content in Foods
Korean researchers have determined the content of the toxic and carcinogenic aldehydes, acetaldehyde and formaldehyde, in a variety of food groups.
Combining the Power of Mass Spectrometry & Microscopy
A tool that provides world-class microscopy and spatially resolved chemical analysis shows considerable promise for advancing a number of areas of study, including chemical science, pharmaceutical development and disease progression.
Increasing Vitamin D Supplementation
New study from ETH Zurich finds that elderly women should consume more vitamin D than previously recommended during the winter months.
Advancing Lithium-Ion Battery Research
The increasing number of components in a lithium-ion battery makes it essential to use a variety of analytical methods to attain complete characterization.
Clearest Ever Images of Enzyme that Plays Key Roles in Aging, Cancer
UCLA-led research on telomerase could lead to new strategies for treating disease
Fruit Fly Pheromone Flags Great Real Estate for Starting a Family
Finding could aid efforts to control mosquito-borne diseases like malaria by manipulating odorants
Education and Expense: The Barriers to Mass Spectrometry in Clinical Laboratories?
Here we examine the perceived barriers to mass spec in clinical laboratories and explore the possible drivers behind the recent shift in uptake of the technology in clinical settings.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos